Physician profile
Collette Mercier
NPI 1598871436
$1,212.79
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $237 · 2021: $299 · 2022: $246 · 2023: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $309.40 | 2020-2023 | Farxiga |
| Esperion Therapeutics, INC. | $249.99 | 2021-2022 | |
| Pfizer INC. | $198.09 | 2019-2020 | |
| Amgen INC. | $175.32 | 2020-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $61.57 | 2022-2023 | |
| Novo Nordisk INC | $50.00 | 2021 | |
| Lilly USA, LLC | $49.95 | 2022-2023 | Mounjaro, Emgality, Jardiance |
| Teva Pharmaceuticals USA, INC. | $39.83 | 2023 | Austedo |
| Glaxosmithkline, LLC. | $23.51 | 2023 | Shingrix |
| Intuitive Surgical, INC. | $18.95 | 2019 | |
| Allergan, INC. | $18.51 | 2020 | |
| Idorsia Pharmaceuticals US INC | $17.67 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collette Mercier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.